FABP4 and I-FABP Levels in Pregnant Women Are Associated with Body Mass Index but Not Gestational Diabetes

Table 2

Spearman correlations of FABP4 and I-FABP levels with other parameters.

Parameter		FABP4			I-FABP
		GDM,	Controls,	Whole group,	GDM,	Controls,	Whole group,
BMI (kg/m^2)		0.68	0.70	0.69	-0.08	-0.35	-0.21
		<0.0001	<0.0001	<0.0001	0.60	0.02	0.06
Fasting glucose (mmol/l)		0.06	0.26	0.11	0.12	0.07	0.04
		0.7	0.09	0.3	0.44	0.66	0.7
Postpartum fasting glucose (mmol/l)		0.14	0.03	0.10	-0.05	0.06	-0.01
		0.37	0.81	0.37	0.73	0.69	0.88
60 glucose (mmol/l)		-0.13	0.24	-0.02	0.05	-0.02	-0.01
		0.38	0.12	0.79	0.75	0.85	0.86
120 glucose (mmol/l)		-0.14	0.23	-0.03	0.07	-0.33	-0.1
		0.37	0.13	0.74	0.65	0.03	0.33
C-peptide (nmol/l)^a		0.7	0.5	0.58	-0.005	-0.13	-0.08
		<0.0001	0.001	<0.0001	0.97	0.4	0.44
Postpartum C-peptide (nmol/l)		0.37	0.45	0.40	-0.16	-0.06	-0.14
		0.01	0.003	0.0002	0.3	0.69	0.20
IL-6 (pg/ml)^b		-0.13	0.26	0.2	-0.39	-0.11	-11
		0.68	0.18	0.22	0.2	0.56	0.48
TNF-α (pg/ml)^b		0.08	0.23	0.21	0.06	0.06	0.09
		0.79	0.24	0.18	0.82	0.77	0.58
Adiponectin (μg/ml)^b		0.19	-0.61	-0.35	0.58	0.17	0.28
		0.54	0.0009	0.02	0.04	0.39	0.08
Leptin (ng/ml)^b		0.26	0.08	0.19	0.32	0.08	0.11
		0.4	0.66	0.23	0.29	0.69	0.49
Resistin (ng/ml)^c		-0.12	-0.02	-0.01	0.67	-0.02	0.17
		0.74	0.91	0.9	0.04	0.91	0.29
EV IgA (EIU)		0.06	0.08	0.03	-0.006	0.13	0.05
		0.68	0.62	0.77	0.96	0.39	0.61
EV IgG (EIU)		0.05	0.17	0.06	0.24	-0.16	0.013
		0.75	0.28	0.57	0.13	0.3	0.9

^aData available for 40 GDM and 39 control women. ^bData available for 12 GDM and 26 control women. ^cData available for 9 GDM and 29 control women.